Justine Huart, François Jouret, Patrizio Lancellotti
{"title":"[Hypertension : two European recommendations, two strategies, one clinical challenge].","authors":"Justine Huart, François Jouret, Patrizio Lancellotti","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>After the joint publication of hypertension management guidelines in 2003, 2007, 2013, and 2018, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided to issue their recommendations separately - ESH in 2023 and ESC in 2024. Notable differences include the ESC's new blood pressure classification, which significantly impacts patient management. Other variations exist in diagnosis and treatment algorithms, yet both approaches remain complementary. Rather than a hurdle, this duality offers valuable flexibility, allowing treatment to be tailored to the patient and the clinician's judgment. The key priority remains: combating therapeutic inertia in this common condition with serious consequences.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"363-368"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale de Liege","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
After the joint publication of hypertension management guidelines in 2003, 2007, 2013, and 2018, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided to issue their recommendations separately - ESH in 2023 and ESC in 2024. Notable differences include the ESC's new blood pressure classification, which significantly impacts patient management. Other variations exist in diagnosis and treatment algorithms, yet both approaches remain complementary. Rather than a hurdle, this duality offers valuable flexibility, allowing treatment to be tailored to the patient and the clinician's judgment. The key priority remains: combating therapeutic inertia in this common condition with serious consequences.